Lista de obras - Yaojun Zhang - Dominio Público Uruguay

18F-fluorodeoxyglucose positron emission tomography in management of pancreatic cystic tumors

artículo científico publicado en 2012

A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy

artículo científico publicado en 2013

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma

artículo científico publicado en 2015

A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

artículo científico publicado en 2015

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma

artículo científico publicado en 2018

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

artículo científico publicado en 2015

Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib

artículo científico publicado en 2015

Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study

artículo científico publicado en 2017

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

artículo científico publicado en 2020

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

scientific article published on 16 December 2020

Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.

artículo científico publicado en 2016

Expert consensus on local ablation therapies for primary liver cancer

artículo científico publicado en 2012

Family history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.

artículo científico publicado en 2013

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

artículo científico publicado en 2014

Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus

artículo científico publicado en 2012

Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.

artículo científico publicado en 2013

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy ⬇️

artículo científico publicado el 2 de julio de 2012

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.

artículo científico publicado en 2014

Higher dietary intakes of choline and betaine are associated with a lower risk of primary liver cancer: a case-control study.

artículo científico publicado en 2017

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

artículo científico publicado en 2015

Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization

artículo científico publicado en 2015

Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy

artículo científico publicado en 2012

Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review

artículo científico

Long-term therapy with sorafenib is associated with pancreatic atrophy.

artículo científico publicado en 2015

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

artículo científico publicado en 2014

Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis

artículo científico publicado en 2016

Novel Percutaneous Radiofrequency Ablation of Portal Vein Tumor Thrombus: Safety and Feasibility ⬇️

artículo científico publicado el 2 de agosto de 2012

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma

artículo científico publicado en 2017

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study

artículo científico publicado en 2016

Percutaneous microwave ablation of larger hepatocellular carcinoma.

artículo científico publicado en 2012

Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation

artículo científico publicado en 2013

Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.

artículo científico publicado en 2012

Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

artículo científico publicado en 2015

Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results ⬇️

artículo científico publicado el 16 de septiembre de 2010

Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study

artículo científico publicado en 2017

Radiofrequency ablation does not induce the significant increase of CD4(+) CD25(+) Foxp3(+) regulatory T cells compared with surgical resection in Hepal-6 tumor model.

artículo científico publicado en 2013

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study

artículo científico publicado en 2012

Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.

artículo científico publicado en 2013

Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.

artículo científico publicado en 2011

Role of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in China

scientific article published on 22 December 2011

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study

scientific article published on 28 May 2020

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study

scientific article published on 05 August 2019

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma

artículo científico publicado en 2015

The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study

artículo científico publicado en 2016

The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients

artículo científico publicado en 2013

The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy

scientific article published on 18 February 2014

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

artículo científico publicado en 2018

The role of miR-10b in metastatic pancreatic ductal adenocarcinoma

artículo científico publicado en 2012

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma

scientific article published on 16 September 2019

Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study

scientific article published on 14 September 2010

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients

artículo científico publicado en 2017

Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

artículo científico publicado en 2012

[Hepatitis B reactivation after treatment for HBV-related hepatocellular carcinoma: comparative analysis of radiofrequency ablation versus hepatic resection]

artículo científico publicado en 2014

Lista de obras de Yaojun Zhang

18F-fluorodeoxyglucose positron emission tomography in management of pancreatic cystic tumors

A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma

A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib

Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.

Expert consensus on local ablation therapies for primary liver cancer

Family history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus

Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy ⬇️

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.

Higher dietary intakes of choline and betaine are associated with a lower risk of primary liver cancer: a case-control study.

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization

Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy

Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review

Long-term therapy with sorafenib is associated with pancreatic atrophy.

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis

Novel Percutaneous Radiofrequency Ablation of Portal Vein Tumor Thrombus: Safety and Feasibility ⬇️

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study

Percutaneous microwave ablation of larger hepatocellular carcinoma.

Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation

Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.

Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results ⬇️

Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study

Radiofrequency ablation does not induce the significant increase of CD4(+) CD25(+) Foxp3(+) regulatory T cells compared with surgical resection in Hepal-6 tumor model.

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study

Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.

Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.

Role of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in China

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma

The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study

The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients

The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

The role of miR-10b in metastatic pancreatic ductal adenocarcinoma

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma

Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients

Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

[Hepatitis B reactivation after treatment for HBV-related hepatocellular carcinoma: comparative analysis of radiofrequency ablation versus hepatic resection]